Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$163,387
-$309,345 QoQ
Shares Held
12,067
-81.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#248
of 626 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgefront Capital, LLC holds $6,932,010 across 7 Drug Manufacturers - General names. OGN ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,888 | $2,003,315 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
15,448 | $1,951,700 | |
| 3 | PFE |
Pfizer Inc
|
59,596 | $1,435,071 | |
| 4 | LLY |
ELI LILLY & Co
|
467 | $560,133 | |
| 5 | NVS |
Novartis AG
|
3,062 | $479,876 | |
| 6 | GSK |
GSK plc
|
6,458 | $338,528 | |
| 7 | OGN |
Organon & Co.
This page
|
12,067 | $163,387 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163,387 | 12,067 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $472,732 | 65,932 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $114,468 | 10,718 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $653,816 | 67,543 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $165,338 | 11,104 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $373,704 | 19,535 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $174,971 | 10,079 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $230,660 | 9,807 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||